期刊文献+

艾司氯胺酮复合丙泊酚应用于肥胖患者宫腔镜检查术的效果

Application of esketamine combined with propofol in Hysteroscopy of obese patients
下载PDF
导出
摘要 目的观察艾司氯胺酮复合丙泊酚麻醉在肥胖患者宫腔镜检查术的应用效果。方法选择2022年1月-6月择期行无痛宫腔镜检查的肥胖患者60例,BMI 30 kg/m^(2)-40 kg/m^(2),随机分为两组(n=30),E组为艾司氯胺酮-丙泊酚组,接受艾司氯胺酮0.25 mg/kg复合丙泊酚1.0 mg/kg麻醉;S组为舒芬太尼-丙泊酚组,接受舒芬太尼0.1μg/kg复合丙泊酚1.0 mg/kg麻醉。记录检查中麻醉效果、术后镇痛效果及术中不良反应发生情况。结果与麻醉开始比较,进镜时、苏醒时两组患者HR、SBP、DBP明显降低(P<0.05)。与S组相比较,E组苏醒时间、复苏时间明显缩短(P<0.05),丙泊酚追加率和丙泊酚追加总量明显减少(P<0.05),苏醒后25 min宫缩痛程度明显降低(P<0.05)。与S组比较,E组托下颌、体动、心动过缓、恶心、呕吐发生率明显降低(P<0.05)。讨论艾司氯胺酮复合丙泊酚麻醉提高了肥胖患者宫腔镜检查术中舒适度,缩短了检查后麻醉恢复时间。 Objective To observe the anesthetic effect of esketamine combined with propofol in hysteroscopy of obese patients.Methods A total of Sixty patients,aged 20-60 years old,with BMI 30 kg/m-40 kg/m^(2),ASA grade Ⅱ or Ⅲ,who underwent elective painless hysteroscopy from January to June 2022 were randomized into 2 groups,Esketamine-Propofol group(group E)and Sufentanilpropofol group(group S),with 30 patients in each group.Group E were slowly given esketamine 0.25 mg/kg followed by propofol 1.0 mg/kg intravenously,while group S was slowly injected with sufentanil 0.1μg/kg followed by slow intravenous propofol 1.0 mg/kg.HR,SBP,DBP and SpO_(2) were recorded immediately after anesthesia,during operation and after recovery.The onset time of anaesthesia,the number of additional cases of propofol,the time of recovery,the residence time of resuscitation room,and the digital analog score(NRS)of uterine pain at 5,15,25 min after recovery were recorded.Moreover,the adverse reactions such as propofol injection pain,jaw support,body movement,dizziness,nausea,vomiting and coughing were recorded.Results Compared with the beginning of anesthesia immediately,HR,SBP and DBP were significantly decreased between the two groups immediately after admission and immediately after recovery(P<0.05),while SpO_(2) had no statistical difference(P>0.05).There was no significant difference in the changes of vital signs between two groups at different times(P>0.05).Compared with group S,the recovery time and dwell time of resuscitation room in group E were significantly shortened(P<0.05),the supplemental rate and total amount of propofol were significantly reduced(P<0.05),and the degree of uterine contraction pain was significantly decreased 25 minutes after recovery(P<0.05).There was no statistical significance in the onset time of anesthesia between two groups(P>0.05).Compared with group S,the incidence of jaw support,body movement,bradycardia,nausea and vomiting in group E was significantly decreased(P<0.05),and there was no statistical significance in pain,dizziness and cough after propofol injection between the two groups(P>0.05).Conclusion Esketamine combined with propofol can improve the anesthesia and postoperative analgesic,accelarate postoperative recovery,strengthen the postoperative anesthesia,and adverse reactions are mild.
作者 马雪萍 瞿莉 徐桂萍 阿里木江·司马义 MA Xueping;QU Li;XU Guiping;Alimujiang Simayi(Department of Anesthesiology,People's Hospital of Xinjiang Uygur Autonomous Region,Xinjiang Clinical Research Center for Anesthesia Management,Urumqi,830001,China)
出处 《新疆医学》 2024年第2期157-160,共4页 Xinjiang Medical Journal
基金 新疆维吾尔自治区人民医院院内项目(项目编号:20200312)。
关键词 艾司氯胺酮 舒芬太尼 丙泊酚 肥胖 宫腔镜 Esketamine Sufentanil Propofol Obesity Hysteroscopy
  • 相关文献

参考文献6

二级参考文献21

  • 1Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy[J]. Clin Pharmacokinet,2000,39(3) :215-231.
  • 2Cortinez LI, De la Fuente N, Eleveld D J, et al. Performance of propofol target-controlled infusion models in the obese: pharma- cokinetic and pharmacodynamic analysis[J]. Anesth Analg, 2014, ll9(2) :302-310.
  • 3lqarashi T, Nagata O, Iwakiri H, et al. Reliability of propofol target-controlled infusion in obese patients[J]. Masui, 2009,58 (10) :1226-1231.
  • 4Ko YP, Hsu YW, Hsu K, et al. Simulation analysis of target- controlled infusion of propofol in Chinese patients[J]. Acta An- aesthesiol Taiwan, 2007,45 ( 3 ) : 141 - 147.
  • 5Albertin A, Poll D, La Colla L, et al. Predictive performance of ' Servin' s formula' during BIS-guided propofol-remifentanil target-controlled infusion in morbidly obese patients[ J]. Br J An- aesth, 2007,98 ( 1 ) : 66-75.
  • 6La Colla L, La Colla G, Albertin A, et al. The use of propofol and remifentardl for the anaesthetic management of a super-obese patient [ J ]. Anaesthesia, 2007,62 ( 8 ) : 842-845.
  • 7Datta Banik S, Das S. Body mass index and body adiposity index in relation to percent body fat: a study in adult men of three en- dogamous groups of South Bengal[ J]. Homo, 2014, pii: S0018- 442X( 14)00101-00102.
  • 8Swinhoe CF, Peacock JE, Glen JB, et al. Evaluation of the predictive performance f a ' Diprifusor' TCI system[ J]. An- aesthesia, 1998,53 Suppl 1:61-67.
  • 9Sandin M, Thorn SE, Dahlqvist A, et al. Effects of pain stimu- lation on bispectral index, heart rate and blood pressure at differ- ent minimal alveolar concentration values of sevoflurane[ J]. Acta Anaesthesiol Scand,2008,52(3) :420-426.
  • 10靳洪涛,李万芳,李慧,李晋,张英豪,张金兰,王爱平,盛彧欣.Beagle犬静脉注射S(+)盐酸氯胺酮和盐酸氯胺酮急性毒性及毒代动力学比较研究[J].中国现代药物应用,2009,3(10):18-20. 被引量:4

共引文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部